Sequenom Misses Nasdaq Deadline to Retain Stock Listing, Though Continues Trading ... | GenomeWeb

NEW YORK, March 16 (GenomeWeb News) - Sequenom yesterday missed its Nasdaq-imposed minimum requirement for continued listing after failing to lift its shares above $1 for at least 10 consecutive trading days over the past six months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.